Introduction
The alveolar gas equation is used to calculate alveolar oxygen partial pressure, as it is impossible to collect gases directly from the alveoli. This equation provides a close estimate of PAO2 inside the alveoli. The variables in the equation can affect the PAO2 inside the alveoli in various physiological and pathophysiological states.
- PAO2 = [(Patm − PH2O) FiO2] − (PaCO2/RQ)
where Patm is the atmospheric pressure (760 mm Hg at sea level), PH2O is the partial pressure of water (approximately 45 mm Hg), FiO2 is the fraction of inspired oxygen, PaCO2 is the partial pressure of carbon dioxide in alveoli (around 40-45 mmHg under normal physiological conditions), and RQ is the respiratory quotient. The value of the RQ can vary depending on the type of diet and metabolic state. RQ is different for carbohydrates, fats, and proteins; the average value is around 0.82 for the human diet. Indirect calorimetry can provide better measurements of RQ by measuring the VO2 (oxygen uptake) and VCO2 (carbon dioxide production).
RQ = amount of CO2 produced/amount of oxygen consumed
At sea level, the alveolar PAO2 is:
- PAO2 = [(760 − 47) 0.21] − (40/0.8) = 99.7 mm Hg.
The 3 major variables of the equation are the atmospheric pressure, amount of inspired oxygen, and carbon dioxide levels. Each variable has an important clinical significance and can help explain physiological and pathophysiological states.[1]
Function
Register For Free And Read The Full Article
- Search engine and full access to all medical articles
- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Function
The alveolar gas equation is crucial in calculating the alveolar-arterial O2 gradient (A-a gradient).
Estimation of the A-a Gradient
- Normal A-a gradient = (Age in years + 10) / 4
- A-a gradient typically increases by 5 to 7 mm Hg for every 10% increase in FiO2.
The arterial PO2 can be determined by obtaining an arterial blood gas. Using the alveolar gas equation, the partial pressure inside the alveoli can be calculated. Carbon dioxide is a crucial variable in the equation. The PO2 in alveoli can change significantly with variations in blood and alveolar carbon dioxide levels. If the rise in CO2 is significant, it can displace oxygen molecules that cause hypoxemia. As atmospheric pressure reduces with increased altitude, the alveolar gas equation helps to calculate the PAO2 within the alveoli. Accurately calculating PAO2 is essential for identifying hypoxemia caused by decreased atmospheric pressure and treating it with appropriate supplemental oxygen levels.[2]
Issues of Concern
The alveolar gas equation is derived from the assumption of a steady-state condition and is only valid if the underlying assumptions remain true. Low FiO2 conditions could violate the steady state. Thus, some clinicians and scientists suggest using the detailed form of the equation. In clinical practice, the complete alveolar gas equation does not convey relevant increased accuracy, and the abbreviated equation discussed above is sufficient in calculating the PO2 in alveoli.
Clinical Significance
Atmospheric Pressure
Increasing altitude decreases the atmospheric pressure; for any given FiO2, there is a lower PO2 in the atmosphere and a lower PAO2 in alveoli. For example, breathing 21% oxygen at sea level results in an alveolar PO2 close to 100 mm Hg, whereas breathing the same percentage of oxygen at Mount Everest (at atmospheric pressure of 263 mm Hg) results in alveolar PO2 close to 0 mm Hg. As we ascend, the reduction in barometric pressure can lead to hypoxemia, triggering various physiological changes.[1][2][3] Common symptoms in decreasing order of frequency include headaches, fatigue, nausea, vomiting, loss of appetite, dizziness, irritability, and disturbed sleep.
The body undergoes several physiological changes that enable it to function in a low-oxygen environment. This process of gradual adjustment is known as acclimatization. This change increases the frequency and depth of breathing, cardiac output, blood pressure, and production of erythropoietin and 2,3-diphosphoglycerate. Without proper acclimatization or supplemental oxygen, individuals can develop high-altitude cerebral edema, acute mountain sickness, and high-altitude pulmonary edema. Conversely, increasing atmospheric pressure can significantly affect the body by increasing the amount of dissolved oxygen in the blood. A hyperbaric oxygen chamber is used as a treatment for significant carbon monoxide poisoning, decompression sickness, and non-healing ulcers.
Inspired Oxygen
Oxygen is used in the human body for oxidative phosphorylation to produce adenosine triphosphate (ATP), the primary energy source for enzymatic reactions. Oxygen has a high redox potential and is the last acceptor of electrons within the electron transport chain. Hypoxemic patients typically present with shortness of breath and dyspnea. If hypoxia is severe, patients may develop severe lactic acidosis, cyanosis, syncope, and arrhythmias.[4][5]
The alveolar gas equation is used to calculate the alveolar and arterial PO2 gradient (A-a) difference.
- Normal A-a gradient = (Age in years + 10) / 4
Every 10% rise in the inspired fraction of oxygen increases the partial pressure of available oxygen in the alveoli by approximately 60 to 70 mm Hg.[6] If more than required FiO2 is given, it can lead to an increase in PO2 within the alveoli, and if given for long periods, this can lead to lung injury. Higher levels of oxygen can be dangerous for patients with end-stage chronic obstructive pulmonary diseases, as their respiratory drive is dependent upon hypoxia (with a PO2 around 60 mm Hg).
Hyperoxygenation, achieved by increasing the PO2 within the alveoli and plasma during intubation or procedural conscious sedation, is highly beneficial and can be easily understood using the alveolar gas equation. For example, at sea level, with no additional supplemental oxygen and under normal physiological conditions, the PO2 inside the alveoli is approximately 100 mm Hg.
- PAO2 = [(Patm − PH2O) FiO2] − (PaCO2/RQ)
For 100% oxygen:
- PAO2 = [(760 − 47) × 1] − (40 / 0.8) = 663 mm Hg
However, if a patient is given 100% oxygen in the same situation, the PO2 can be as high as 663 mm Hg. under normal physiological conditions, this provides a clinician 8 to 9 minutes to successfully intubate before a patient's partial pressure of oxygen falls below 60 mm Hg and desaturation on pulse oximetry becomes evident.
Under pathological conditions where diffusion is impaired, such as heart failure, pneumonia, or alveolar hemorrhage, without pre-oxygenation, the clinician may have a few seconds to a few minutes before the patient desaturates. Under these severe pathological conditions, it is recommended that an experienced clinician attempt the intubation. In these conditions, bilevel positive airway pressure can be used to pre-oxygenate and even hyperventilate the patient as long as they are hemodynamically stable, alert, awake, and able to protect the airway.
Carbon Dioxide
Carbon dioxide is the end product of carbohydrate metabolism. Carbon dioxide is transported by red blood cells, mostly bound to the hemoglobin, to the lungs from peripheral tissues, where it diffuses out and allows hemoglobin to bind to oxygen (Bohr and Haldane effects). Importantly, any increase in carbon dioxide must result in a decrease in the PO2. For example, if a patient is breathing room air with 0.21 FiO2 and is at sea level, an increase in PaCO2 from 40 to 80 mm Hg decreases the PAO2 from 100 to approximately 60 mm Hg, leading to hypoxemia. This scenario emphasizes the importance of continuous capnography and pulse oximetry, especially during procedures where conscious sedation is used.
In hypoxic conditions, the normal response is hyperventilation and increasing the minute ventilation to exhale more carbon dioxide, which decreases the partial pressure of carbon dioxide and increases PO2 to some extent. For example, a 10 mm Hg decrease in alveoli PCO2 can increase the PO2 by approximately 10 to 12 mm Hg, which can be significant in acute and chronic disease processes essential for survival.[7]
Other Issues
The alveolar gas equation has limitations, especially in low atmospheric pressures and low-inspired FiO2. With acclimatization, severe acidosis, and carbon monoxide poisoning, the body's physiology and pathophysiology change substantially, and the equation cannot be used reliably.
Enhancing Healthcare Team Outcomes
The alveolar gas equation is used to calculate alveolar oxygen partial pressure, as it is impossible to collect gases directly from the alveoli. The equation helps calculate and closely estimate the PaO2 inside the alveoli.
Enhancing healthcare team outcomes in the context of understanding and applying the alveolar gas equation requires a multifaceted approach involving various healthcare professionals.
Clinicians
- Skills and responsibilities:
- Thorough understanding of respiratory physiology and the alveolar gas equation.
- Ability to interpret arterial blood gas results in conjunction with the alveolar gas equation.
- Diagnosis and treatment of respiratory conditions.
- Strategy and ethics:
- Ensure accurate diagnosis and appropriate treatment plans based on alveolar gas equation calculations.
- Communicate findings and treatment plans clearly to other team members and patients.
- Consider the ethical implications of treatment decisions, especially in critical care situations.
Advanced Practice Providers
- Skills and responsibilities:
- Proficiency in performing and interpreting arterial blood gas tests.
- Ability to apply the alveolar gas equation in clinical practice.
- Monitoring patient response to respiratory interventions.
- Strategy and ethics:
- Collaborate closely with clinicians to ensure consistent application of the alveolar gas equation in patient care.
- Educate patients and families about respiratory health and treatments.
- Advocate for patient safety and comfort during respiratory interventions.
Nurses
- Skills and responsibilities:
- Understanding the basics of the alveolar gas equation and its clinical relevance.
- Proficiency in collecting arterial blood gas samples and monitoring oxygen therapy.
- Recognizing signs of respiratory distress.
- Strategy and ethics:
- Implement clinician-ordered treatments based on alveolar gas equation calculations.
- Monitor patients closely for changes in their respiratory status.
- Ensure patient comfort and dignity during respiratory care.
Respiratory Therapists
- Skills and responsibilities:
- Expert knowledge of the alveolar gas equation and its practical applications.
- Proficiency in administering various forms of respiratory therapy.
- Ability to adjust ventilator settings based on alveolar gas equation calculations.
- Strategy and ethics:
- Collaborate with clinicians to optimize respiratory care plans.
- Educate other team members on the nuances of respiratory physiology and therapy.
- Ensure proper use and maintenance of respiratory equipment.
Pharmacists
- Skills and responsibilities:
- Knowledge of medications that can affect respiratory function and gas exchange.
- Understanding how drug therapies can impact alveolar gas equation variables.
- Ability to recommend appropriate medications for respiratory conditions.
- Strategy and ethics:
- Collaborate with the healthcare team to optimize medication regimens for respiratory patients.
- Provide guidance on potential drug interactions that may affect respiratory function.
- Ensure safe and effective use of respiratory medications.
Clinical Laboratory Scientists
- Skills and responsibilities:
- Expertise in arterial blood gas analysis techniques.
- Ability to troubleshoot and maintain blood gas analyzers.
- Understanding of pre-analytical factors affecting arterial blood gas results.
- Strategy and ethics:
- Ensure that arterial blood gas results are obtained and reported promptly and accurately to enable the correct application of the alveolar gas equation.
- Collaborate with other team members to interpret complex or unusual results.
- Maintain quality control standards for arterial blood gas testing.
Interprofessional Communication and Care Coordination
- Regular team meetings to discuss complex respiratory cases and share insights from different perspectives.
- Implementation of standardized communication protocols for reporting critical arterial blood gas results and alveolar gas equation calculations.
- Development of interdisciplinary care plans incorporating the alveolar gas equation.
- Use of electronic health records to document and share alveolar gas equation calculations and related interventions.
- Collaborative research projects to improve the application of the alveolar gas equation in clinical practice.
Enhancing Patient-Centered Care
- Educating patients and families about the importance of the alveolar gas equation in managing their respiratory health.
- Involving patients in decision-making processes related to respiratory treatments.
- Tailoring oxygen therapy and other interventions based on individual patient needs and preferences.
- Providing culturally competent care that considers diverse patient backgrounds and beliefs.
Improving Patient Safety and Team Performance
- Implementing double-check systems for critical alveolar gas equation calculations.
- Conducting regular training sessions on the use and interpretation of the alveolar gas equation.
- Developing and adhering to evidence-based protocols for respiratory care based on alveolar gas equation principles.
- Encouraging a culture of open communication where team members can voice concerns or suggestions related to respiratory care.
- Conducting regular audits and quality improvement initiatives to enhance the team's proficiency in applying the alveolar gas equation.
By leveraging the diverse skills and perspectives of the healthcare team, implementing effective communication strategies, and focusing on patient-centered care, the application of the alveolar gas equation can significantly enhance patient outcomes, safety, and overall team performance in respiratory care.
References
Diehl JL, Mercat A, Pesenti A. Understanding hypoxemia on ECCO(2)R: back to the alveolar gas equation. Intensive care medicine. 2019 Feb:45(2):255-256. doi: 10.1007/s00134-018-5409-0. Epub 2018 Oct 15 [PubMed PMID: 30324288]
Level 3 (low-level) evidenceBashar FR, Vahedian-Azimi A, Farzanegan B, Goharani R, Shojaei S, Hatamian S, Mosavinasab SMM, Khoshfetrat M, Khatir MAK, Tomdio A, Miller AC, MORZAK Collaborative. Comparison of non-invasive to invasive oxygenation ratios for diagnosing acute respiratory distress syndrome following coronary artery bypass graft surgery: a prospective derivation-validation cohort study. Journal of cardiothoracic surgery. 2018 Nov 27:13(1):123. doi: 10.1186/s13019-018-0804-8. Epub 2018 Nov 27 [PubMed PMID: 30482210]
Level 1 (high-level) evidenceVan Iterson EH, Olson TP. Use of 'ideal' alveolar air equations and corrected end-tidal PCO(2) to estimate arterial PCO(2) and physiological dead space during exercise in patients with heart failure. International journal of cardiology. 2018 Jan 1:250():176-182. doi: 10.1016/j.ijcard.2017.10.021. Epub 2017 Oct 7 [PubMed PMID: 29054325]
Zavorsky GS, Hsia CC, Hughes JM, Borland CD, Guénard H, van der Lee I, Steenbruggen I, Naeije R, Cao J, Dinh-Xuan AT. Standardisation and application of the single-breath determination of nitric oxide uptake in the lung. The European respiratory journal. 2017 Feb:49(2):. pii: 1600962. doi: 10.1183/13993003.00962-2016. Epub 2017 Feb 8 [PubMed PMID: 28179436]
Conkin J. Equivalent Air Altitude and the Alveolar Gas Equation. Aerospace medicine and human performance. 2016 Jan:87(1):61-4. doi: 10.3357/AMHP.4421.2016. Epub [PubMed PMID: 26735235]
Roy TK, Secomb TW. Theoretical analysis of the determinants of lung oxygen diffusing capacity. Journal of theoretical biology. 2014 Jun 21:351():1-8. doi: 10.1016/j.jtbi.2014.02.009. Epub 2014 Feb 20 [PubMed PMID: 24560722]
Nose H. [Conditions under which alveolar air equations are modified and the compensation terms of saturated water vapor in those equations]. Masui. The Japanese journal of anesthesiology. 2005 Apr:54(4):427-35 [PubMed PMID: 15852634]